lobbying_activities: 1697108
Data license: Public Domain (U.S. Government data) · Data source: Federal Register API & Regulations.gov API
This data as json
| id | filing_uuid | filing_type | registrant_name | registrant_id | client_name | filing_year | filing_period | issue_code | specific_issues | government_entities | income_amount | expense_amount | is_no_activity | is_termination | received_date |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1697108 | b25c4b1a-c4c0-4229-a2c8-4a7aa169a2a2 | Q2 | CHRISTY ELLERBEE CONSULTING, LLC | 401103332 | INDIVIOR, PLC (FKA RECKITT BENCKISER PHARMACEUTICALS, INC.) | 2015 | second_quarter | PHA | Pharmaceutical issues relevant to Indivior, PLC; S. 1455 TREAT Act. | HOUSE OF REPRESENTATIVES,SENATE | 0 | 0 | 2015-07-15T15:20:49.887000-04:00 |